Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. L.A. (Lisa) de Jong

dr. L.A. (Lisa) de Jong

Postdoctoral Researcher Global Health Economics
Profile picture of dr. L.A. (Lisa) de Jong
E-mail:
l.a.de.jong rug.nl

Research interests

Lisa has a background in pharmacy and conducted her doctoral research 'Health economics of direct oral anticoagulants in the Netherlands' at the department of Pharmacotherapy, -epidemiology, and -economics — University of Groningen. Her research focusses on health economic modelling for reimbursement and clinical decision-making purposes, with special interest in using real-world data to populate models and expertise in cardiorenal metabolic diseases. Currently, Lisa is involved in various research projects and technical appraisals for the National Institute for Health and Care Excellence in the UK. Expertise: pharmacoeconomics, health economics, burden of disease, budget impact, health technology assessment, cost-effectiveness.

Publications

A Systematic Review of Health-Related Quality of Life in Women with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab

Differences in evidentiary requirements for oncology drug effectiveness assessments among six European health technology assessment bodies: can alignment be improved?

Budget and health impact of switching eligible patients with atrial fibrillation to lower- dose dabigatran

Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland

Cost-Effectiveness Models of Continuous Glucose Monitoring in Individuals With Type 1 Diabetes: A Systematic Review on Methodology and Quality

Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands

Facing problems in radiotherapy for breast cancer patients in Yogyakarta, Indonesia: A cohort retrospective study

Model and Empirical Data-Based Cost-Utility Studies of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Protocol of a Systematic Review on Methodology and Quality

The Use of eHealth for Pharmacotherapy Management With Patients With Respiratory Disease, Cardiovascular Disease, or Diabetes: Scoping Review

Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings

Read more